Listed

Nephros Inc: Form 10-Q for the period ended Jun 30, 2022

Filed with the SEC on Aug 15, 2022 and accepted by EDGAR at Aug 15, 2022, 16:45 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2022-04-01 to 2022-06-30$2.9mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2022-01-01 to 2022-06-30$5.1mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2022-04-01 to 2022-06-30$1.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2022-01-01 to 2022-06-30$2.7mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2022-04-01 to 2022-06-30$1.4mus-gaap:GrossProfit
Gross profit6 months2022-01-01 to 2022-06-30$2.4mus-gaap:GrossProfit
Research and development3 months2022-04-01 to 2022-06-30$431.0kus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2022-01-01 to 2022-06-30$1.0mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2022-04-01 to 2022-06-30$2.1mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2022-01-01 to 2022-06-30$4.4mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2022-04-01 to 2022-06-30−$1.2mus-gaap:OperatingIncomeLoss
Operating income6 months2022-01-01 to 2022-06-30−$3.2mus-gaap:OperatingIncomeLoss
Interest expense3 months2022-04-01 to 2022-06-30$6.0kus-gaap:InterestExpense
Interest expense6 months2022-01-01 to 2022-06-30$13.0kus-gaap:InterestExpense
Income tax3 months2022-04-01 to 2022-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2022-01-01 to 2022-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2022-04-01 to 2022-06-30−$1.1mus-gaap:NetIncomeLoss
Net income6 months2022-01-01 to 2022-06-30−$3.1mus-gaap:NetIncomeLoss
Basic EPS3 months2022-04-01 to 2022-06-30−$0.12us-gaap:EarningsPerShareBasic
Basic EPS6 months2022-01-01 to 2022-06-30−$0.31us-gaap:EarningsPerShareBasic
Operating cash flow6 months2022-01-01 to 2022-06-30−$2.9mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2022-01-01 to 2022-06-30$137.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-06-30$4.2mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-06-30$11.1mus-gaap:AssetsCurrent
Total assetsAt period end2022-06-30$15.0mus-gaap:Assets
Current liabilitiesAt period end2022-06-30$2.1mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-06-30$2.5mus-gaap:Liabilities
Long-term debtAt period end2022-06-30$210.0kus-gaap:LongTermDebt
Shareholders' equityAt period end2022-06-30$9.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-22-022929. Last ingested by Listed: Nov 13, 2026, 16:20 ET. Listed shows no prices and gives no investment advice.